Case report · 2 Jan 2026
CommentaryPublished 28 Jan 2021
HRP2 and HRP3 and the Performance of Diagnostic Tests for Malaria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As mentioned in the recently published article, currently, there is little evidence to document the true extent of HRP mutations worldwide. In countries where malaria is endemic, it is necessary to evaluate the genetic variability of the HRP2 and HRP3 genes in order to determine which mutations are present in each country with a view to improving the diagnosis and interpretation of the results obtained by Rapid Tests (RDT) and molecular factors, which could reduce the occurrence of false negatives and, in the medium and long term, improve malaria management programs and interventions [1].
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Disease and Pathology.
Case report · 2 Jan 2026
Single-Cell Technologies Advance Infection, Inflammation Insights
Short communication · 2 Jan 2026
Climate Fuels Global Vector-Borne Disease Spread
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Disease and Pathology
- SubjectInfectious Diseases
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “María Luz Gunturiz Albarracín”